Page 90 - GPD-2-4

Gene & Protein in Disease Gene polymorphism and chronic kidney disease

Conflict of interest 5. Chapter 1: Definition and classification of CKD. Kidney Int
Suppl (2011), 2013, 3(1): 19–62.
The authors declare that they have no competing interests.
https://doi.org/10.1038/kisup.2012.64
Author contributions 6. Jha V, Garcia-Garcia G, Iseki K, et al., 2013, Chronic

Conceptualization: Devendra Kumar, Syed Tasleem Raza kidney disease: Global dimension and perspectives. Lancet,
Formal analysis: Jalees Fatima, Ajay Mishra 382(9888): 260–272.
Investigation: Aseem Yadav https://doi.org/10.1016/S0140-6736(13)60687-X
Methodology: Saliha Rizvi 7. Rajapurkar MM, John GT, Kirpalani AL, et al., 2012, What
Writing—original draft: Saliha Rizvi do we know about chronic kidney disease in India: First
Writing—review & editing: Saliha Rizvi, Farheen Khan report of the Indian CKD registry. BMC Nephrol, 13: 10.

Ethics approval and consent to participate https://doi.org/10.1186/1471-2369-13-10
8. Singh AK, Farag YM, Mittal BV, et al., 2013, Epidemiology
This study was performed in accordance with the and risk factors of chronic kidney disease in India - results
Declaration of Helsinki. The protocol and procedures from the SEEK (Screening and Early Evaluation of Kidney
employed were reviewed and approved by the Institutional Disease) study. BMC Nephrol, 14: 114.
Ethical Committee, Era’s Lucknow Medical College https://doi.org/10.1186/1471-2369-14-114
and Hospital, Lucknow, India (Approval no.: Rcell
EC/2020/78). A written informed consent was obtained 9. Varma PP, 2015, Prevalence of chronic kidney disease in
from all the subjects before sample collection to participate India - Where are we heading? Indian J Nephrol, 25(3): 133–135.
in the study. 10. Alkady MM, Abdel-Messeih PL, El-Fishawy HS, et al.,
2020, Evaluation of chemokine receptor 2 polymorphism
Consent for publication in patients with end-stage renal disease. J Egypt Soc Nephrol
The authors affirm that human research participants Transpl, 20(3): 151–156.
provided informed consent for publication of their data. https://doi.org/10.4103/jesnt.jesnt_2_20

Availability of data 11. Li HD, You YK, Shao BY, et al., 2022, Roles and crosstalks
of macrophages in diabetic nephropathy. Front Immunol,
Data used in this work are available from the corresponding 13: 1015142.
author on reasonable request. https://doi.org/10.3389/fimmu.2022.1015142
References 12. Nakajima K, Tanaka Y, Nomiyama T, et al., 2002, Chemokine
receptor genotype is associated with diabetic nephropathy
1. Sarnak MJ, Levey AS, Schoolwerth AC, et al., 2003, Kidney in Japanese with type 2 diabetes. Diabetes, 51(1): 238–242.
disease as a risk factor for development of cardiovascular
disease: A statement from the American Heart Association https://doi.org/10.2337/diabetes.51.1.238
Councils on Kidney in Cardiovascular Disease, High Blood 13. Gao J, Liu X, Wei L, et al., 2016, Genetic variants of MCP-1
Pressure Research, Clinical Cardiology, and Epidemiology and CCR2 genes and IgA nephropathy risk. Oncotarget,
and Prevention. Circulation, 108(17): 2154–2169. 7: 77950–77957.
https://doi.org/10.1161/01.CIR.0000095676.90936.80 https://doi.org/10.18632/oncotarget.12847
2. Coresh J, Selvin E, Stevens LA, et al., 2007, Prevalence of 14. Zhang M, Ardlie K, Wacholder S, et al., 2006, Genetic
chronic kidney disease in the United States. JAMA, 298(17): variations in CC chemokine receptors and hypertension.
2038–2047. Am J Hypertens, 19(1): 67–72.
https://doi.org/10.1001/jama.298.17.2038 https://doi.org/10.1016/j.amjhyper.2005.06.025
3. Plantinga LC, Boulware LE, Coresh J, et al., 2008, Patient 15. Kitagawa K, Wada T, Furuichi K, et al., 2004, Blockade of
awareness of chronic kidney disease: Trends and predictors. CCR2 ameliorates progressive fibrosis in kidney. Am J
Arch Intern Med, 168(20): 2268–2275. Pathol, 165(1): 237–246.
https://doi.org/10.1001/archinte.168.20.2268 https://doi.org/10.1016/S0002-9440(10)63292-0
4. Mills KT, Xu Y, Zhang W, et al., 2015, A systematic analysis 16. Sezgin I, Koksal B, Bagci G, et al., 2011, CCR2 polymorphism
of worldwide population-based data on the global burden of in chronic renal failure patients requiring long-term
chronic kidney disease in 2010. Kidney Int, 88(5): 950–957. hemodialysis. Intern Med, 50(21): 2457–2461.
https://doi.org/10.1038/ki.2015.230 https://doi.org/10.2169/internalmedicine.50.5119

Volume 2 Issue 4 (2023) 7 https://doi.org/10.36922/gpd.2253